The Atlantic Pediatric Device Consortium provides a national platform to translate ideas through the product development pathway all the way to commercialization.  With funding from the FDA Office of Orphan Products Development, our mission is to enhance the lives of children through the development of novel pediatric medical devices which are both safe and effective.  The Consortium fosters an environment of creativity, where innovative ideas are reviewed, tested, and developed by a multidisciplinary team of experts from the Georgia Institute of Technology, Emory University, and Children’s Healthcare of Atlanta.  With its roots firmly established in the Atlanta engineering and medical communities, in 2013 APDC was awarded renewal funding from the FDA and has expanded its geographical footprint along the east coast to include the Virginia Commonwealth University

 

What's New
Atlanta-based consortium on leading edge of pediatric device development.
GCMI and APDC partnering on MedTech Innovation Series 2014
Round 1 winners will present their pediatric device projects to a panel of expert reviewers who will provide feedback and final evaluation.
Projects
The Norwood Procedure is the first in a series of palliative surgical procedures to treat Hypoplastic Left Heart Syndrome (HLHS), one of the most complex congenital heart defects. A simple concept for providing better outcomes for the Norwood Procedure is to utilize a valved RV-PA conduit. This approach would limit regurgitation into the remaining functional ventricle, thus avoiding right heart hypertrophy.
The CellScope Oto(TM) device is a smartphone otoscope system that includes a simple attachment to convert a standard smartphone into a digital otoscope with data transmission capabilities. The Remotoscope thus enables diagnosis of ear infections in children by a remote physician.
PneumoKazoo is an easy-to-use, noninvasive, disposable solution for collecting lung speciomens to better diagnose pneumonia in children. PneumoKazoo uses fluid mechanics to separate the upper airway particles from the lower airway particles so that only a lung specimen is captured on the filter at the end of the device.